While this shift has not been achieved consistently and requires ongoing education, training, and commitment on the part of agencies and their officers, many victims are benefiting from this shift where it is occurring (Clawson, Dutch, & Cummings, 2006)
52 Further, the safety and tolerability of MSCs as a treatment for AD have been shown in a phase 1 clinical trial
Whereas the microbe-gut-brain axis connects the gut to the brain, and the enteric nervous system (ENS) exists at the interface between the microbiota and the host, the ENS is structurally and neurochemically similar to the CNS, and thus the pathogenic mechanisms that give rise to ENS disorders may also lead to CNS dysfunction and the nerves connecting the ENS to the CNS may act as a conduit for disease transmission (50)
The published menu spans 8+ compounds, which is unusually deep for a regional market
Several unanswered questions remain regarding: Long-term receptor adaptation Extended safety observations Pharmacokinetic variability Biological mechanisms Combination pathway interactions These questions are common during the development of novel peptide-based compounds
